Elucidating the exact pharmacological mechanism of action (MOA) of naturally transpiring compounds might be tough. Even though Tarselli et al. (60) made the first de novo synthetic pathway to conolidine and showcased this naturally occurring compound efficiently suppresses responses to equally chemically induced and inflammation-derived pain, the pharmacologic focus https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers